Veterinary Vaccines

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

• Study Reliability and Reporting Limitations
• Disclaimers
• Data Interpretation & Reporting Level
• Quantitative Techniques & Analytics
• Product Definitions and Scope of Study
• A. Companion Animal Vaccines
• B. Livestock Vaccines
  • Porcine Vaccines
  • Bovine Vaccines
  • Poultry Vaccines
  • Ovine Vaccines
  • Equine Vaccines
  • Other Animal Vaccines

II. EXECUTIVE SUMMARY

1. Industry Overview & Outlook

• Global Animal Health Care Industry - A Brief Review
• Table 1: Global Animal Health Products Market by Region(2006E): Percentage Share Breakdown by Value Sales forEurope, North America, Latin America and Rest of World(includes corresponding Graph/Chart)
• Table 2: Global Animal Health Products Market by ProductGroup (2006E): Percentage Share Breakdown by Value salesfor Parasiticides, Vaccines, Anti-Infectives, Medical FeedAdditives and Other Pharmaceuticals (includescorresponding Graph/Chart)
• Scope of the Report
• Current And Future Analysis

2. Market Trends & Issues

• Companion Animal Vaccines: Trailing on a HighGrowth Track
• OTC Market: A Potential Threat for Veterinarians
• Parasiticides, Systemic Agents To Drive The Market
• Taxonomy of Vaccines
• Bird Flu - The Aftermath
• Avian Flu Vaccine Development Faces Tough Times
• Vaccination - Critical for Controlling AvianInfluenza Virus

3. Product Overview

• Vaccines - An Evolutionary Scan
• Contribution of Animal Research to Vaccine Production
• Veterinary Medicines- A Brief Review
• Preventive Medicines
• Therapeutic Medicines
• Others
• Veterinary Vaccines - An Essential Component ofAnimal Health Care
• What Does A Veterinary Vaccine Do?
• Classification of Veterinary Vaccines
• Companion Animal Vaccines
• Canine Vaccines
• Feline Vaccines
• Livestock Vaccines
• Bovine Vaccines
• Poultry Vaccines
• Ovine Vaccines
• Porcine Vaccines
• Equine Vaccines
• Aquaculture Vaccines
• A Tabular Analysis on Select Animal DiseasesControlled by Vaccines
• Vaccination and Its Reactions
• Veterinary Vaccines- Latest Breakthroughs
• Marker vaccines
• DNA vaccines
• Gene-deleted vaccines
• Viral-vectored vaccines

4. Notes on Select Animal Diseases

• Brucellosis
• Tuberculosis
• Johne’s disease
• Spirochete Associated Diseases
• Respiratory Disease in Goats, Sheep, and Cattle
• Latest Breakthrough
• Porcine Respiratory Diseases
• Mastitis
• African Swine Fever
• Avian Influenza
• East Coast Fever
• Hemorrhagic Septicemia
• Foot-And-Mouth Disease
• Japanese Encephalitis
• Rift Valley Fever

5. Product Innovations/Introductions

• Merial Rolls Out Vaxxitek® HVT+IBD Hatchery Vaccinefor Poultry Industry
• Intervet & FLI Develop Dual Vaccine Prototype for Birds
• Schering-Plough Receives USDA License for itsRhusigen™ Erysipelas Vaccine
• USDA Approves Use of PreveNile™ Vaccine for Horses
• Fort Dodge Animal Health Develops Reverse GeneticsAvian Vaccine
• Boehringer Ingelheim’s Swine Vaccine Gains Approvalin Australia
• Merial Limited Gets USDA Approval for DNA Vaccinefor Melanoma in Dogs
• Embrex’s Poultry Vaccine Inovocox Gets USDAApproval
• Skystar Bio-Pharmaceutical Develops Avian InfluenzaVaccine
• USDA Grants Conditional License for Necrotic EnteritisVaccine
• Fort Dodge Receives USDA License for Pyramid®10
• USDA Licenses Use of Fort Dodge’s Suvaxyn® PCV2Vaccine in Pigs
• USDA Grants Conditional License to Pfizer’s NewCanine Vaccine
• Continuum ™ DAP Vaccine from Intervet
• Lohmann Unveils Vaccine for Gumboro Disease
• New Vaccine for Bovine Respiratory Disease
• Corpoica & Limor Introduce Cattle Vaccine
• Chiron to Roll Out Rabies Vaccine in China
• Heska Launches Feline UltraNasal(TM) Vaccines
• Merial Unveils Two PUREVAX® RespiratoryVaccines
• Schering-Plough Introduces MaxiVac® H1N1and MaxiVac® H3N2
• Fort Dodge Unveils FLUVAC
• LAHI Augments Tad Lohmann Vaccine Portfolio
• Institute of Animal Husbandry and VeterinaryBiologicals Develops Vaccine for Blue Tongue
• Bioject and Animal Medical Center ReleasesDNA Vaccine
• Agri Laboratories Introduces Master Guard KV/MLV
• Schering-Plough Animal Health LaunchesParacox™-5 in Europe
• Aventis Pasteur Rolls Out Dengue Fever Vaccine
• Embrex Unveils Bursa-BDA (NP), A NewPoultry Vaccine

6. Recent Industry Activity

• Pfizer Animal Health Acquires Embrex
• Schering-Plough to Acquire Intervet
• Schering-Plough to Acquire Organon
• Intervet Sets Up New Animal Vaccine Production Facilityin Boxmeer
• Crucell Licenses PER.C6® Technology to PfizerAnimal Health
• CVRL to Synthesize New Animal Vaccines
• Pfizer to Shut Down Omaha Animal Vaccine Center
• IGI Inc Licenses Novasomes to Novavax
• IPB Collaborates with Shigeta for Vaccine Production
• Suguna Poultry Steps into Livestock Vaccine
• Production Business
• European Medicines Agency Grants CommunityAuthorization for Nobilis Influenza H7N1
• AVANT & Pfizer Collaborate to DevelopAnimal Vaccines
• Intervet Acquires FMD Vaccine Production Facilityfrom Bayer Healthcare
• CFIA Authorizes Bioniche E. Coli O157:H7 Cattle Vaccinefor Field Use
• Hemispherx Biopharma Acquires DOGS Molecule Patent
• Hind Industries to Establish Animal VaccineFormulations Plant at Patiala
• Cryosite and Animal Health Australia Form Partnership
• Hester Pharmaceuticals Plans Capacity Expansion
• Biovet Pvt Ltd to Set up Animal Vaccine Plant inKarnataka
• IPB and Shigeta Establish JV for Production ofCLOSE 5.1 Vaccine
• IPB Shigeta Acquires Bird Flu Vaccine Rights fromMedImmune
• Bioject Signs Three Agreements With Merial
• PetCARE signs US distribution agreement with ButlerAnimal Health Supply
• Poultry Vaccine to be produced in Vladimir
• DEFRA Against Vaccine Usage For Bird Flu
• Butler & Burns Complete Business Merger
• Ivax Completes Phoenix Scientific’s Acquisition
• Crucell Signs Licensing Agreement with Merial
• Charlesbank Acquires Walco
• Imugene Signs an Agreement with Abic Biological
• Vical Licenses Core Technology to Merial
• Pfizer Acquires CSL’s Veterinary Vaccines Business
• PT Bio Farma Plans to Join Hands with QiluPharmaceutical
• Antigenics Sells Feline Leukemia Vaccine Unit
• Embrex Establishes Novel In Ovo Vaccine Plant
• Indian Immunological Bags Order for Foot andMouth Disease Vaccine
• Crucell Issues West Nile Virus Vaccine License to Pfizer
• Kimron Veterinary Signs a License Agreementwith Crucell
• Akzo Constructs Manufacturing Unit in Boxmeer
• Novartis Acquires Grand Laboratories andImmTech Biologics
• Schering-Plough Purchases Aquaculture Vaccines
• Bioject Enters into a Licensing and SupplyingAgreement with Merial
• Hester Pharmaceuticals Inks ManufacturingAgreement with Sinsui
• Heska and Dolphin Medical Enter into a Partnership Deal
• Merck Offers its Veterinary Manual Online
• Avant Announces Distributor for Megan HealthPoultry Vaccines
• VectoGen Obtains Exclusive License from CommonwealthScientific & Industrial Research Organization
• Ranbaxy Animal Health Ties Up with Ceva SanteAnimale
• Crucell and Vaxin Collaborate to Formulate NeedleLess Vaccines
• Patterson Dental Company Buys J. A. Webster, Inc.,
• Bayer Ties up with Bundesforschungsanstalt furViruskrankheiten der Tiere
• Origen and Embrex Receive ATP Grant
• Fort Dodge Animal Health Receives Approval forVaccine

7. Research and Development

• Scientists Develop New Vaccine Against DiseaseRelated to PCV2
• Auburn University and Vaxin Researchers DevelopAvian Flu Vaccine
• UK Researchers Develop In-Shell Vaccine for Chicks
• Researchers in Vietnam Decode the H5N1 Virus Gene
• Pittsburgh Researchers Create Avian Flu Vaccine fromH5N1 Virus
• University of Warwick Develops Protecting Virus Method
• New Treatment Measure Against Ovine Salmonella& Brucellosis
• ICAR Develops Indigenous Bird Flu Vaccine
• St. Jude Develops Flu Virus Vaccine through ReverseGenetics
• Researchers Develop Vaccine for Swine Disease
• Researchers Develop Experimental Vaccine Against 1918Influenza Virus
• Study Proves Effectiveness of Intradermal VaccineAdministration in Rabbits
• CEL-SCI’s CEL-1000 Peptide Shows Adjuvant Activity
• Progress in Vaccine for Canine Cancer
• Vaccine for Avian Flu Developed
• Vector for DNA Vaccine Developed
• Bovine Herpesvirus 1 VP22Improves the Efficiencyof DNA Vaccine
• Vaccine Against Canine Flu Underway
• Study on Immunity in Dogs
• New Sheep Vaccine in Clinical Trials
• Commercialization of Poultry Vaccine Underway
• Vaccine for B. Anthracis Developed
• Efficacy of E.Coli 0157 Vaccine Demonstrated
• SARS Vaccine in Progress
• Calgary-based Biotechnology Company to developOral Vaccine for Cattle Against Pneumonia
• Vaccine for Tick-Borne Disease Underway
• Feline Immunodeficiency Virus Rhinotracheitis Vaccinefor Cats Under Trials
• Japanese Study on Bird Flu Vaccine
• Heska Instigates Clinical Trials For The DevelopmentOf Canine Cancer Product
• Invention of new Vaccine Skin Patches and Nasal Sprays
• Sequencing of A Genetic Code To PreventMarek' s Disease
• Discovery of a New Immunomodulation Treatment toFight Against Feline Leukemia Virus
• Invention of a DNA Vaccine to Inoculate Fetal Lambs
• Prodigene Instigates the Immunization Process withthe Edible Vaccines
• Invention of a new Trivalent Vaccine for Protectionfrom Mastiffs
• IVT Invents VacciMax™ a New Vaccine Technology

8. Focus on Select Global Players

• AVANT Immunotherapeutics, Inc (USA)
• Megan Health, Inc. (USA)
• Bayer HealthCare AG (Germany)
• Fort Dodge Animal Health (USA)
• Heska Corporation (USA)
• Imugene Limited (Australia)
• Intervet International B.V. (The Netherlands)
• Merial Animal Health Ltd. (UK)
• Pfizer, Inc. (USA)
• Embrex, Inc. (USA)
• Protein Sciences Corporation (USA)
• Schering-Plough (USA)
• Virbac Corporation (USA)

9. Global Market Perspective

• Table 3: World Recent Past, Current & Future Analysis forVeterinary Vaccines by Geographic Region - US, Europe andRest of World Markets Independently Analyzed with AnnualSales Figures in US$ Million for Years 2000 through2010 (includes corresponding Graph/Chart)
• Table 4: World Long-term Projections for Veterinary Vaccinesby Geographic Region - US, Europe and Rest of World MarketsIndependently Analyzed with Annual Sales Figures inUS$ Million for Years 2011 through 2015 (includescorresponding Graph/Chart)
• Table 5: World 10-Year Perspective for Veterinary Vaccines byGeographic Region - Percentage Breakdown of Dollar Salesfor US, Europe and Rest of World Markets for Years 2000,2006 & 2010 (includes corresponding Graph/Chart)
• Table 6: World Recent Past, Current & Future Analysis forCompanion Animal Vaccines by Geographic Region - US,Europe and Rest of World Markets Independently Analyzedwith Annual Sales Figures in US$ Million for Years 2000through 2010 (includes corresponding Graph/Chart)
• Table 7: World Long-term Projections for Companion AnimalVaccines by Geographic Region - US, Europe and Rest of WorldMarkets Independently Analyzed with Annual Sales Figures inUS$ Million for Years 2011through 2015(includescorresponding Graph/Chart)
• Table 8: World 10-Year Perspective for CompanionAnimal Vaccines by Geographic Region - PercentageBreakdown of Dollar Sales for US, Europe andRest of World Markets for Years 2000, 2006 & 2010(includes corresponding Graph/Chart)
• Table 9: World Recent Past, Current & Future Analysis forCompanion Animal Vaccines by Product Segment- CanineVaccines & Feline Vaccines Markets Independently Analyzedwith Annual Sales Figures in US$ Million for Years 2000through 2010 (includes corresponding Graph/Chart)
• Table 10: World Long-term Projections for Companion AnimalVaccines by Product Segment- Canine Vaccines & FelineVaccines Markets Independently Analyzed with Annual SalesFigures in US$ Million for Years 2011 through 2015(includes corresponding Graph/Chart)
• Table 11: World 10-Year Perspective for CompanionAnimal Vaccines by Product Segment - PercentageBreakdown of Dollar Sales for Canine Vaccines &Feline Vaccines Markets for Years 2000, 2006 & 2010
• Table 12: World Recent Past, Current & Future Analysis forCanine Vaccines by Geographic Region - US, Europe andRest of World Markets Independently Analyzed with AnnualSales Figures in US$ Million for Years 2000 through 2010(includes corresponding Graph/Chart)
• Table 13: World Long-term Projections for Canine Vaccines byGeographic Region - US, Europe and Rest of World MarketsIndependently Analyzed with Annual Sales Figures inUS$ Million for Years 2011 through 2015(includescorresponding Graph/Chart)
• Table 14: World 10 - Year Perspective for Canine Vaccines byGeographic region - Percentage Breakdown of Dollar Salesfor US, Europe and Rest of World Markets for Years 2000,2006 & 2010 (includes correspondingGraph/Chart)
• Table 15: World Recent Past, Current & Future Analysis forFeline Vaccines by Geographic Region - US, Europe andRest of World Markets Independently Analyzed withAnnual Sales Figures in US$ Million for Years 2000through 2010 (includes correspondingGraph/Chart)
• Table 16: World Long-term Projections for Feline Vaccines byGeographic Region - US, Europe and Rest of World MarketsIndependently Analyzed with Annual Sales Figures inUS$ Million for Years 2011 through 2015(includescorresponding Graph/Chart)
• Table 17: World 10 - Year Perspective for Feline Vaccinesby Geographic Region - Percentage Breakdown ofDollar Sales for US, Europe and Rest of World Marketsfor Years 2000, 2006 & 2010 (includescorresponding Graph/Chart)
• Table 18: World Recent Past, Current & Future Analysis forLivestock Vaccines by Geographic Region - US, Europe andRest of World Markets Independently Analyzed with AnnualSales Figures in US$ Million for Years 2000 through2010 (includes corresponding Graph/Chart)
• Table 19: World Long-term Projections for Livestock Vaccinesby Geographic Region - US, Europe and Rest of World MarketsIndependently Analyzed with Annual Sales Figures inUS$ Million for Years 2011 through 2015 (includescorresponding Graph/Chart)
• Table 20: World 10 - Year Perspective for Livestock Vaccinesby Geographic Region - Percentage Breakdown of DollarSales for US, Europe and Rest of World Markets for Years2000, 2006 & 2010 (includes correspondingGraph/Chart)
• Table 21: World Recent Past, Current & Future Analysis forLivestock Vaccines by Product Segment - Porcine Vaccines,Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, EquineVaccines & Other Animal Vaccines Markets IndependentlyAnalyzed with Annual Sales Figures in US$ Million forYears 2000 through 2010 (includes correspondingGraph/Chart)
• Table 22: World Long-term Projections for Livestock Vaccinesby Product Segment - Porcine Vaccines, Bovine Vaccines,Poultry Vaccines, Ovine Vaccines, Equine Vaccines & OtherAnimal Vaccines Markets Independently Analyzed with AnnualSales Figures in US$ Million for Years 2011 through2015(includes corresponding Graph/Chart)
• Table 23: World 10-Year Perspective for LivestockVaccines by Product Segment - Percentage Breakdownof Dollar Sales for Porcine Vaccines, Bovine Vaccines,Poultry Vaccines, Ovine Vaccines, Equine Vaccines &Other Animal Vaccines Markets for Years 2000, 2006 &2010 (includes corresponding Graph/Chart)
• Table 24: World Recent Past, Current & Future Analysisfor Porcine Vaccines by Geographic Region - US, Europeand Rest of World Markets Independently Analyzed withAnnual Sales Figures in US$ Million for Years 2000through 2010 (includes corresponding Graph/Chart)
• Table 25: World Long-term Projections for Porcine Vaccines byGeographic Region - US, Europe and Rest of World MarketsIndependently Analyzed with Annual Sales Figures inUS$ Million for Years 2011 through 2015(includescorresponding Graph/Chart)
• Table 26: World 10 - Year Perspective for Porcine Vaccines byGeographic region - Percentage Breakdown of Dollar Salesfor US, Europe and Rest of World Markets for Years 2000,2006 & 2010 (includes corresponding Graph/Chart)
• Table 27: World Recent Past, Current & Future Analysisfor Bovine Vaccines by Geographic Region - US, Europeand Rest of World Markets Independently Analyzed withAnnual Sales Figures in US$ Million for Years 2000through 2010 (includes corresponding Graph/Chart)
• Table 28: World Long-term Projections for Bovine Vaccines byGeographic Region - US, Europe and Rest of World MarketsIndependently Analyzed with Annual Sales Figures inUS$ Million for Years 2011 through 2015(includes corresponding Graph/Chart)
• Table 29: World 10 - Year Perspective for Bovine Vaccines byGeographic region - Percentage Breakdown of Dollar Salesfor US, Europe and Rest of World Markets for Years 2000,2006 & 2010 (includes corresponding Graph/Chart)
• Table 30: World Recent Past, Current & Future Analysisfor Poultry Vaccines by Geographic Region - US, Europeand Rest of World Markets Independently Analyzed withAnnual Sales Figures in US$ Million for Years 2000through 2010 (includes corresponding Graph/Chart)
• Table 31: World Long-term Projections for Poultry Vaccines byGeographic Region - US, Europe and Rest of World MarketsIndependently Analyzed with Annual Sales Figures inUS$ Million for Years 2011 through 2015(includescorresponding Graph/Chart)
• Table 32: World 10 - Year Perspective for Poultry Vaccines byGeographic region - Percentage Breakdown of Dollar Salesfor US, Europe and Rest of World Markets for Years 2000,2006 & 2010 (includes corresponding Graph/Chart)
• Table 33: World Recent Past, Current & Future Analysisfor Ovine Vaccines by Geographic Region - US, Europeand Rest of World Markets Independently Analyzed withAnnual Sales Figures in US$ Million for Years 2000through 2010 (includes corresponding Graph/Chart)
• Table 34: World Long-term Projections for Ovine Vaccines byGeographic Region - US, Europe and Rest of World MarketsIndependently Analyzed with Annual Sales Figures inUS$ Million for Years 2011 through 2015(includescorresponding Graph/Chart)
• Table 35: World 10 - Year Perspective for Ovine Vaccines byGeographic region - Percentage Breakdown of Dollar Salesfor US, Europe and Rest of World Markets for Years 2000,2006 & 2010 (includes corresponding Graph/Chart)
• Table 36: World Recent Past, Current & Future Analysis forEquine Vaccines by Geographic Region - US, Europe andRest of World Markets Independently Analyzed with AnnualSales Figures in US$ Million for Years 2000 through2010 (includes corresponding Graph/Chart)
• Table 37: World Long-term Projections for Equine Vaccines byGeographic Region - US, Europe and Rest of World MarketsIndependently Analyzed with Annual Sales Figures inUS$ Million for Years 2011 through 2015 (includescorresponding Graph/Chart)
• Table 38: World 10 - Year Perspective for Equine Vaccines byGeographic region - Percentage Breakdown of Dollar Salesfor US, Europe and Rest of World Markets for Years 2000,2006 & 2010 (includes corresponding Graph/Chart)
• Table 39: World Recent Past, Current & Future Analysis forOther Animal Vaccines by Geographic Region - US, Europeand Rest of World Markets Independently Analyzed withAnnual Sales Figures in US$ Million for Years 2000through 2010 (includes corresponding Graph/Chart)
• Table 40: World Long-term Projections for Other AnimalVaccines by Geographic Region - US, Europe andRest of World Markets Independently Analyzed withAnnual Sales Figures in US$ Million for Years 2011through 2015(includes corresponding Graph/Chart)
• Table 41: World 10 - Year Perspective for Other AnimalVaccines by Geographic region - Percentage Breakdown ofDollar Sales for US, Europe and Rest of World Markets forYears 2000, 2006& 2010 (includes correspondingGraph/Chart)

III. MARKET

1. The United States

• A. Market Analysis
  • Current & Future Analysis
  • Key Trends/Issues
  • H5N1 Virus: A Conundrum for the USIndustry
  • Relatively Slow Growth on Cards for VeterinaryVaccines
  • Rabies Cases in the US (2005)
  • Table 42: Leading Players in the US Rabies VaccinesMarket (1995): Percentage Market Share for Pfizer,Fort Dodge, Solvay, Rhone Merieux and Others(includes corresponding Graph/Chart)
  • US and Europe Join Hands to Develop VeterinaryVaccines (2000)
  • Strategic Developments
  • Product Launches/ Developments
  • Key US Players
  • AVANT Immunotherapeutics, Inc (USA)
  • Megan Health Inc.
  • Fort Dodge Animal Health
• Heska Corporation
  • Intervet, Inc.
  • Pfizer Inc
  • Embrex, Inc
  • Protein Sciences Corporation
  • Schering-Plough
  • Virbac Corporation
• B. Market Analytics
  • Table 43: US Recent Past, Current & Future Analysis forVeterinary Vaccines by Product Group/Segment -Companion Animal Vaccines (Canine & Feline Vaccines),Livestock Vaccines (Porcine Vaccines, Bovine Vaccines,Poultry Vaccines, Ovine Vaccines, Equine Vaccines &Other Animal Vaccines) Markets IndependentlyAnalyzed with Annual Sales Figures in US$ Millionfor Years 2000 through 2010 (includescorresponding Graph/Chart)
  • Table 44: US Long-term Projections for VeterinaryVaccines by Product Group/Segment - Companion AnimalVaccines (Canine & Feline Vaccines), Livestock Vaccines(Porcine Vaccines, Bovine Vaccines, Poultry Vaccines,Ovine Vaccines, Equine Vaccines & Other Animal Vaccines)Markets Independently Analyzed with Annual Sales Figuresin US$ Million for Years 2011 through 2015(includescorresponding Graph/Chart)
  • Table 45: US 10-Year Perspective for Veterinary Vaccinesby Product Group/Segment - Percentage Breakdown ofDollar Sales for Companion Animal Vaccines (CanineVaccines & Feline Vaccines), Livestock Vaccines (PorcineVaccines, Bovine Vaccines, Poultry Vaccines, OvineVaccines, Equine Vaccines & Other Animal Vaccines)Markets for 2000, 2006 & 2010 (includescorresponding Graph/Chart)

2. Europe

• A. Market Analysis
  • Overview
  • Partnerships - The need of the Hour
  • Current & Future Analysis
  • Strategic Development
  • Product Launch
• B. Market Analytics
  • Table 46: European Recent Past, Current & FutureAnalysis for Veterinary Vaccines by Geographic Region -France, Germany, Italy, United Kingdom and Rest ofEurope Markets Independently Analyzed with AnnualSales Figures in US$ Million for Years 2000 through2010 (includes corresponding Graph/Chart)
  • Table 47: European Long-term Projections for VeterinaryVaccines by Geographic Region - France, Germany, Italy,United Kingdom and Rest of Europe Markets IndependentlyAnalyzed with Annual Sales Figures in US$ Million forYears 2011 through 2015 (includes correspondingGraph/Chart)
  • Table 48: European 10-Year Perspective for VeterinaryVaccines by Geographic Region - Percentage Breakdownof Dollar Sales for France, Germany, Italy, UnitedKingdom and Rest of Europe for Years 2000,2006 & 2010 (includes correspondingGraph/Chart)
  • Table 49: European Recent Past, Current & Future Analysisof Veterinary Vaccines by Product Group/Segment -Companion Animal Vaccines (Canine Vaccines andFeline Vaccines) and Livestock Vaccines (PorcineVaccines, Bovine Vaccines, Poultry Vaccines, OvineVaccines, Equine Vaccines and Other Animal Vaccines)Markets Independently Analyzed with Annual SalesFigures in US$ Million for Years 2000 through2010 (includes correspondingGraph/Chart)
  • Table 50 : European Long-term Projections for VeterinaryVaccines by Product Group/Segment - Companion AnimalVaccines (Canine & Feline Vaccines), Livestock Vaccines(Porcine Vaccines, Bovine Vaccines, Poultry Vaccines,Ovine Vaccines, Equine Vaccines & Other AnimalVaccines) Markets Independently Analyzed withAnnual Sales Figures in US$ Million for Years 2011through 2015(includes correspondingGraph/Chart)
  • Table 51: European 10 - Year Perspective for VeterinaryVaccines by Product Group/Segment - Companion AnimalVaccines (Canine Vaccines and Feline Vaccines) andLivestock Vaccines (Porcine Vaccines, Bovine Vaccines,Poultry Vaccines, Ovine Vaccines, Equine Vaccines andOther Animal Vaccines) Markets for Years 2000,2006 & 2010 (includes correspondingGraph/Chart)

2a. France

• A. Market Analysis
  • Current & Future Analysis
  • Strategic Development
  • Product Launch
• B. Market Analytics
  • Table 52: French Recent Past, Current & Future Analysisfor Veterinary Vaccines by Product Group/Segment -Companion Animal Vaccines (Canine Vaccines & FelineVaccines), Livestock Vaccines (Porcine Vaccines, BovineVaccines, Poultry Vaccines, Ovine Vaccines & EquineVaccines) Markets Independently Analyzed with AnnualSales Figures in US$ Million for Years 2000 through2010 (includes correspondingGraph/Chart)
  • Table 53: French Long-term Projections for VeterinaryVaccines by Product Group/Segment - Companion AnimalVaccines (Canine & Feline Vaccines), Livestock Vaccines(Porcine Vaccines, Bovine Vaccines, Poultry Vaccines,Ovine Vaccines, & Equine Vaccines) Markets IndependentlyAnalyzed with Annual Sales Figures in US$ Million forYears 2011 through 2015(includes correspondingGraph/Chart)
  • Table 54: French 10-Year Perspective for VeterinaryVaccines by Product Group/Segment - PercentageBreakdown of Dollar Sales for Companion AnimalVaccines (Canine Vaccines & Feline Vaccines),Livestock Vaccines (Porcine Vaccines, Bovine Vaccines,Poultry Vaccines, Ovine Vaccines & Equine Vaccines)Markets for 2000, 2006 & 2010 (includescorresponding Graph/Chart)

2b. Germany

• A. Market Analysis
  • Current & Future Analysis
  • Strategic Developments
  • Key German Players
  • Bayer HealthCare AG
• B. Market Analytics
  • Table 55: German Recent Past, Current & FutureAnalysis for Veterinary Vaccines by Product Group/Segment - Companion Animal Vaccines (CanineVaccines & Feline Vaccines), Livestock Vaccines(Porcine Vaccines, Bovine Vaccines, Poultry Vaccines,Ovine Vaccines & Equine Vaccines) MarketsIndependently Analyzed with Annual SalesFigures in US$ Million for Years 2000through 2010 (includes correspondingGraph/Chart)
  • Table 56: German Long-term Projections for VeterinaryVaccines by Product Group/Segment - Companion AnimalVaccines (Canine & Feline Vaccines), Livestock Vaccines(Porcine Vaccines, Bovine Vaccines, Poultry Vaccines,Ovine Vaccines, & Equine Vaccines) Markets IndependentlyAnalyzed with Annual Sales Figures in US$ Million forYears 2011 through 2015(includes correspondingGraph/Chart)
  • Table 57: German 10-Year Perspective for VeterinaryVaccines by Product Group/Segment - PercentageBreakdown of Dollar Sales for Companion AnimalVaccines (Canine Vaccines & Feline Vaccines),Livestock Vaccines (Porcine Vaccines, Bovine Vaccines,Poultry Vaccines, Ovine Vaccines & Equine Vaccines)Markets for 2000, 2006 & 2010 (includescorresponding Graph/Chart)

2c. Italy

• A. Market Analysis
  • Current & Future Analysis
• B. Market Analytics
  • Table 58: Italian Recent Past, Current & Future Analysisfor Veterinary Vaccines by Product Group/Segment -Companion Animal Vaccines (Canine Vaccines & FelineVaccines), Livestock Vaccines (Porcine Vaccines, BovineVaccines, Poultry Vaccines, Ovine Vaccines, EquineVaccines & Other Animal Vaccines) MarketsIndependently Analyzed with Annual SalesFigures in US$ Million for Years 2000 through2010 (includes corresponding Graph/Chart)
  • Table 59: Italian Long-term Projections for VeterinaryVaccines by Product Group/Segment - CompanionAnimal Vaccines (Canine & Feline Vaccines), LivestockVaccines (Porcine Vaccines, Bovine Vaccines, PoultryVaccines, Ovine Vaccines, Equine Vaccines & OtherAnimal Vaccines) Markets Independently Analyzedwith Annual Sales Figures in US$ Million forYears 2011 through 2015 (includescorresponding Graph/Chart)
  • Table 60: Italian 10-Year Perspective for VeterinaryVaccines by Product Group/Segment - PercentageBreakdown of Dollar Sales for Companion AnimalVaccines (Canine Vaccines & Feline Vaccines),Livestock Vaccines (Porcine Vaccines, Bovine Vaccines,Poultry Vaccines, Ovine Vaccines, Equine Vaccines &Other Animal Vaccines) Markets for 2000, 2006 &2010 (includes corresponding Graph/Chart)

2d. The United Kingdom

• A. Market Analysis
  • Current & Future Analysis
  • Strategic Development
  • Product Launches
  • Key Player in UK
  • Merial Animal Health Ltd
• B. Market Analytics
  • Table 61: UK Recent Past, Current & Future Analysis forVeterinary Vaccines by Product Group/Segment -Companion Animal Vaccines (Canine Vaccines & FelineVaccines), Livestock Vaccines (Porcine Vaccines, BovineVaccines, Poultry Vaccines, Ovine Vaccines, EquineVaccines & Other Animal Vaccines) Markets IndependentlyAnalyzed with Annual Sales Figures in US$ Million forYears 2000 through 2010 (includes correspondingGraph/Chart)
  • Table 62: UK Long-term Projections for VeterinaryVaccines by Product Group/Segment - Companion AnimalVaccines (Canine & Feline Vaccines), Livestock Vaccines(Porcine Vaccines, Bovine Vaccines, Poultry Vaccines,Ovine Vaccines, Equine Vaccines & Other AnimalVaccines) Markets Independently Analyzed withAnnual Sales Figures in US$ Million for Years 2011through 2015(includes correspondingGraph/Chart)
  • Table 63: UK 10-Year Perspective for Veterinary Vaccinesby Product Group/Segment - Percentage Breakdown ofDollar Sales for Companion Animal Vaccines (CanineVaccines & Feline Vaccines), Livestock Vaccines (PorcineVaccines, Bovine Vaccines, Poultry Vaccines, OvineVaccines, Equine Vaccines &Other Animal Vaccines)Markets for 2000, 2006 & 2010 (includescorresponding Graph/Chart)

2e. Rest of Europe

• A. Market Analysis
  • Overview
  • A Note on Danish Veterinary Services inthe Recent Past
  • The 2002 Standards of Danish Medicines recommendtest for antibody inducing fragments inveterinary vaccines
  • Hungary Vaccinates Birds Across Zoos
  • Russia Mass-Produces Vaccines Against Avian Flu
  • Product Launches/Developments
  • Strategic Developments
  • Focus on Select Players
  • Intervet International B.V. (The Netherlands)
• B. Market Analytics
  • Table 64: Rest of Europe Recent Past, Current & FutureAnalysis for Veterinary Vaccines - by Product Group/Segment for Companion Animal Vaccines (Canine Vaccines& Feline Vaccines), Livestock Vaccines (Porcine Vaccines,Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, EquineVaccines & Other Animal Vaccines) Markets IndependentlyAnalyzed with Annual Sales Figures in US$ Million forYears 2000 through 2010 (includes correspondingGraph/Chart)
  • Table 65: Rest of Europe Long-term Projections forVeterinary Vaccines by Product Group/Segment -Companion Animal Vaccines (Canine & Feline Vaccines),Livestock Vaccines (Porcine Vaccines, Bovine Vaccines,Poultry Vaccines, Ovine Vaccines, Equine Vaccines &Other Animal Vaccines) Markets Independently Analyzedwith Annual Sales Figures in US$ Million for Years 2011through 2015(includes correspondingGraph/Chart)
  • Table 66: Rest of Europe 10-Year Perspective forVeterinary Vaccines by Product/Segment - PercentageBreakdown of Dollar Sales for Companion AnimalVaccines (Canine Vaccines & Feline Vaccines),Livestock Vaccines (Porcine Vaccines, Bovine Vaccines,Poultry Vaccines, Ovine Vaccines, Equine Vaccines &Other Animal Vaccines) Markets for 2000, 2006 &2010 (includes corresponding Graph/Chart)

3. Rest of World

• A. Market Analysis
  • Overview
  • Vaccine-Resistant H5N1 Bird Infection HitsSoutheast Asia
  • Focus on Select Regions
  • Canada
  • Overview of Canadian Animal Health Industry
  • Import and Manufacture of VeterinaryBiologics
  • First to Access E. coli 0157:H7 Vaccine
  • China
  • China Initiates Mass Vaccination CampaignAgainst Bird Flu Virus
  • Australia
  • A Note on Australian Veterinary TherapeuticsMarket
  • India
  • ICAR Develops Indigenous Bird Flu Vaccine
  • Thailand
  • Japan & Thailand to Cooperate for DevelopingBird Flu Vaccine
  • Malaysia
  • Malaysia Initiates Measures to Deal withPotential Flu Pandemic
  • Kazakhstan
  • Kazakhstan Takes Proactive Measures AgainstBird Flu
  • North Korea
  • North Korea Develops Bird Flu Vaccine
  • Vietnam
  • Vietnam to Mass-Produce Bird Flu Vaccines
  • Vietnam Imports Bird Flu Vaccinefrom Russia
  • Bird Flu Outbreak- 2003
  • Egypt
  • Egypt Reports H5N1 Infection in VaccinatedFlocks
  • Kenya
  • Kenya to Mass-Manufacture Vaccines AgainstRift Valley Fever
  • Strategic Developments
  • Product Launches/Developments
  • Focus on Select players
  • Immunovaccine Technologies Inc. (Canada)
  • Imugene Limited (Australia)
  • Indian Immunologicals Ltd (India)
  • Merial Australia Pty Ltd (Australia)
• B. Market Analytics
  • Table 67: Rest of World Recent Past, Current & FutureAnalysis for Veterinary Vaccines - by Product Group/Segment for Companion Animal Vaccines (CanineVaccines & Feline Vaccines), Livestock Vaccines(Porcine Vaccines, Bovine Vaccines, Poultry Vaccines,Ovine Vaccines, Equine Vaccines & Other AnimalVaccines) Markets Independently Analyzed with AnnualSales Figures in US$ Million for Years 2000 through2010 (includes corresponding Graph/Chart)
  • Table 68: Rest of World Long-term Projections forVeterinary Vaccines by Product Group/Segment -Companion Animal Vaccines (Canine & FelineVaccines), Livestock Vaccines (Porcine Vaccines,Bovine Vaccines, Poultry Vaccines, Ovine Vaccines,Equine Vaccines & Other Animal Vaccines) MarketsIndependently Analyzed with Annual Sales Figures inUS$ Million for Years 2011 through 2015(includescorresponding Graph/Chart)
  • Table 69: Rest of World 10-Year Perspective forVeterinary Vaccines by Product Group/Segment -Percentage Breakdown of Dollar Sales for CompanionAnimal Vaccines (Canine Vaccines & Feline Vaccines),Livestock Vaccines (Porcine Vaccines, Bovine Vaccines,Poultry Vaccines, Ovine Vaccines, Equine Vaccines &Other Animal Vaccines) Markets for 2000, 2006 &2010 (includes correspondingGraph/Chart)

IV. COMPETITION

• 1. Akzo Nobel NV (The Netherlands)
  • Table 70: Annual Sales Analysis: 2004-2006(In € billion)
  • Table 71: Annual Sales Analysis by Segment:2006 Vs. 2005 (In € billion)
  • Table 72: Annual Sales Analysis by GeographicRegion: 2006 Vs. 2005 (In € billion)
  • Table 73: Annual Sales Analysis by Segment:2005 Vs. 2004 (In € billion)
  • Table 74: Annual Sales Analysis by GeographicRegion: 2005 Vs. 2004 (In € billion)
  • Akzo Nobel (USA)
  • Intervet International BV (The Netherlands)
  • Intervet, Inc. (USA)
  • Intervet Danmark A/S (Denmark)
  • Intervet India Ltd. (India)
  • Intervet Norge AS (Norway)
  • Intervet UK Ltd. (UK)
  • Agvax Developments Ltd. (New Zealand)
• 2. Alpharma, Inc. (USA)
  • Table 75: Annual Sales Analysis: 2003-2005(In US$ million)
  • Table 76: Quarterly Sales Analysis: 2004-2005(In US$ million)
  • Table 77: Annual Sales Analysis by BusinessSegment: 2004-2005 (In US$ million)
  • Table 78: Annual Sales Analysis by GeographicRegion: 2004-2005 (In US$ million)
  • Table 79: Annual Sales Analysis by BusinessSegment: 2003-2004 (In US$ million)
  • Table 80: Annual Sales Analysis by GeographicRegion: 2003-2004 (In US$ million)
• 3. Animal Health Australia (Australia)
  • Table 81: Annual Sales Analysis: 2006 Vs. 2005(In A$ million)
• 4. Avant Immunotherapeutics, Inc. (USA)
  • Table 82: Annual Sales Analysis: 2004-2006(In US$ million)
  • Table 83: Annual Sales Analysis by Quarter:2006 Vs. 2005 (In US$ million)
  • Table 84: Annual Sales Analysis by Quarter:2005 Vs. 2004 (In US$ million)
  • Megan Health, Inc. (USA)
• 5. Bayer HealthCare AG (Germany)
  • Table 85: Annual Sales Analysis: 2005 Vs. 2004(In € million)
  • Table 86: Annual Sales Analysis by Segment:2005 Vs. 2004 (In € million)
  • Table 87: Annual Sales Analysis by GeographicRegion: 2005 Vs. 2004 (In € million)
  • Bayer Healthcare - Animal Health Division (Germany)
• 6. Benchmark Biolabs, Inc. (USA)
• 7. Bharat Biotech International Ltd. (India)
• 8. Bioject Medical Technologies, Inc. (USA)
  • Table 88: Annual Sales Analysis: 2004-2006(In US$ million)
  • Table 89: Annual Sales Analysis by Quarter:2006 Vs. 2005 (In US$ million)
  • Table 90: Annual Sales Analysis by Product:2006 Vs. 2005 (In US$ million)
  • Table 91: Annual Sales Analysis by GeographicRegion: 2006 Vs. 2005 (In US$ million)
  • Table 92: Annual Sales Analysis by Quarter:2005 Vs. 2004 (In US$ million)
  • Table 93: Annual Sales Analysis by Product:2005 Vs. 2004 (In US$ million)
  • Table 94: Annual Sales Analysis by GeographicRegion: 2005 Vs. 2004 (In US$ million)
• 9. Bioniche Animal Health, Inc. (USA)
• 10. Bioniche Life Sciences, Inc. (Canada)
  • Table 95: Annual Sales Analysis: 2006 Vs. 2005(In C$ million)
  • Table 96: Quarterly Sales Analysis: 2006 Vs. 2005(In C$ million)
  • Table 97: Annual Sales Analysis by Segment:2006 Vs. 2005 (In C$ million)
  • Table 98: Annual Sales Analysis by GeographicRegion: 2006 Vs. 2005 (In C$ million)
• 11. Biovac Ltd. (Israel)
• 12. Biovet Pvt Ltd. (India)
• 13. Bioveta, A.S. (Czech Republic)
• 14. Biowet Pulawy Ltd./Biowet Pulawy SP. z.o.o. (Poland)
• 15. Boehringer Ingelheim GmbH (Germany)
  • Boehringer Ingelheim Animal Health GmbH (Germany)
  • Boehringer Ingelheim Ltd. (UK)
  • Boehringer Ingelheim Pharmaceuticals, Inc. (USA)
  • Boehringer Ingelheim Vetmedica, Inc. (USA)
• 16. Brilliant Industries Ltd. (INDIA)
• 17. Butler Animal Health Supply, LLC (USA)
• 18. Central Veterinary Research Laboratory (CVRL)(UAE)
• 19. Chevita GmbH (Germany)
• 20. Crucell NV (The Netherlands)
  • Table 99: Annual Sales Analysis: 2006 Vs. 2005(In € million)
• 21. Cryosite (Australia)
• 22. CSL Limited (Australia)
  • Table 100: Annual Sales Analysis: 2004-2006(In A$ million)
  • Table 101: Annual Sales Analysis by BusinessSegment: 2006 Vs. 2005 (In A$ million)
  • Table 102: Annual Sales Analysis by GeographicRegion: 2006 Vs. 2005 (In A$ million)
• 23. DVM Pharmaceuticals, Inc. (USA)
• 24. Dyntec Spol. S R.O. (Czech Republic)
• 25. GHEN Corporation (Japan)
• 26. Hemispherx Biopharma Inc. (USA)
• 27. Henry Schein, Inc. (USA)
  • Table 103: Nine Months Sales Analysis:2005-2006 (Nine Months Ended, September)(In US$ million)
  • Table 104: Nine Months Sales Analysis by Quarter:2005-2006 (Nine Months Ended, September)(In US$ million)
  • Table 105: Nine Months Sales Analysis by BusinessSegment: 2005-2006 (Nine Months Ended,September) (In US$ million)
  • Table 106: Annual Sales Analysis: 2004-2005(In US$ million)
  • Table 107: Annual Sales Analysis by Quarter:2004-2005 (In US$ million)
  • Table 108: Annual Sales Analysis by BusinessSegment: 2004-2005 (In US$ million)
  • Table 109: Annual Sales Analysis by GeographicRegion: 2004-2005 (In US$ million)
• 28. Heska Corporation (USA)
  • Table 110: First Quarter Sales Analysis:2005-2006 (Q1) (In US$ million)
  • Table 111: First Quarter Sales Analysis bySegment: 2005-2006 (Q1) (In US$ million)
  • Table 112: Annual Sales Analysis: 2003-2005(In US$ million)
  • Table 113: Annual Sales Analysis by Segment:2004-2005 (In US$ million)
  • Table 114: Annual Sales Analysis by GeographicRegion: 2004-2005 (In US$ million)
• 29. Hester Pharmaceuticals Limited (India)
• 30. Hind Industries Ltd. (India)
  • Table 115: Nine Months Sales Analysis: 2007 Vs. 2006(Nine Months Ended, December) (In INR Lacs)
  • Table 116: Nine Months Sales Analysis by Quarter:2007 Vs. 2006 (Nine Months Ended, December)(In INR Lacs)
  • Table 117: Annual Sales Analysis: 2006 Vs. 2005(In INR Lacs)
• 31. IDT Impfstoffwerk Dessau-Tornau GmbH (Germany)
• 32. IGI Inc. (USA)
  • Table 118: First Quarter Sales Analysis:2007 Vs. 2006 (In US$ million)
  • Table 119: Annual Sales Analysis: 2006 Vs. 2005(In US$ million)
• 33. ImmunoVaccine Technologies, Inc. (Canada)
• 34. Imugene Limited (Australia)
  • Table 120: Annual Sales Analysis: 2004-2005(In A$ million)
• 35. Indian Immunologicals Ltd. (India)
• 36. Indovax (India)
• 37. IZO SpA (Italy)
• 38. Komipharm International Co., Ltd. (Korea)
• 39. Kyoto Biken Laboratories, Inc. (Japan)
• 40. Large Scale Biology Corporation (USA)
  • Table 121: Half Yearly Sales Analysis:2004-2005 (H1) (In US$ million)
  • Table 122: Annual Sales Analysis: 2003-2004(In US$ million)
  • Table 123: Annual Sales Analysis by Quarter:2003-2004 (In US$ million)
• 41. Lohmann Animal Health GmbH & Co., KG. (Germany)
  • Lohmann Animal Health International (USA)
• 42. Malaysian Vaccines And Pharmaceuticals Sdn. Bhd.(MVP) (Malaysia)
• 43. Malta Vaccines Limited (Malta)
• 44. Medco-Erp Ltd. (Holland)
• 45. Merial Limited (UK)
  • Merial Animal Health Ltd. (United Kingdom)
  • Mérial (France)
  • Merial (USA)
  • Merial Australia Pty Ltd (Australia)
  • Merial GmbH (Germany)
  • Merial New Zealand Ltd. (New Zealand)
  • Merial Norden A/S (Denmark)
• 46. Neogen Corporation (USA)
  • Table 124: Nine Months Sales Analysis:2005-2006 (Nine Months Ended, February)(In US$ million)
  • Table 125: Nine Months Sales Analysis by Quarter:2005-2006 (Nine Months Ended, February)(In US$ million)
  • Table 126: Nine Months Sales Analysis by Segment:2005-2006 (Nine Months Ended, February)(In US$ million)
  • Table 127: Annual Sales Analysis: 2003-2005(In US$ million)
  • Table 128: Annual Sales Analysis by Quarter:2004-2005 (In US$ million)
  • Table 129: Annual Sales Analysis by Segment:2004-2005 (In US$ million)
  • Table 130: Annual Sales Analysis by Product:2004-2005 (In US$ million)
  • Table 131: Annual Sales Analysis by Segment:2003-2004 (In US$ million)
  • Table 132: Annual Sales Analysis by Product:2003-2004 (In US$ million)
• 47. Novartis Animal Health (Switzerland)
  • Novartis Animal Health US, Inc. (USA)
• 48. Pfizer, Inc. (USA)
  • Table 133: Half Yearly Sales Analysis:2006 Vs. 2005 (In US$ million)
  • Table 134: Half Yearly Sales Analysis by Quarter:2006 Vs. 2005 (In US$ million)
  • Table 135: Half Yearly Sales Analysis by BusinessSegment: 2006 Vs. 2005 (In US$ million)
  • Table 136: Half Yearly Sales Analysis by GeographicRegion: 2006 Vs. 2005 (In US$ million)
  • Table 137: Annual Sales Analysis: 2005 Vs. 2004(In US$ million)
  • Embrex, Inc. (USA)
  • Table 138: First Quarter Sales Analysis:2005-2006 (Q1) (In US$ million)
  • Table 139: First Quarter Sales Analysis by BusinessSegment: 2005-2006 (Q1) (In US$ million)
  • Table 140: First Quarter Sales Analysis by GeographicRegion: 2005-2006 (Q1) (In US$ million)
  • Table 141: Annual Sales Analysis: 2004-2005(In US$ million)
  • Table 142: Annual Sales Analysis by Quarter:2004-2005 (In US$ million)
  • Table 143: Annual Sales Analysis by BusinessOperation: 2004-2005 (In US$ million)
  • Table 144: Annual Sales Analysis by GeographicRegion: 2004-2005 (In US$ million)
  • Pfizer Animal Health Div (USA)
  • Pfizer Animal Health (South Africa)
  • Pfizer Animal Health SA-NV (Belgium)
  • Pfizer Australia Pty., Ltd. (Australia)
  • Pfizer GmbH (Germany)
  • Pfizer Italiana SpA (Italy)
• 49. PHL Associates, Inc. (USA)
• 50. Protein Sciences Corporation (USA)
• 51. Ranbaxy Laboratories Ltd. (India)
  • Table 145: Annual Sales Analysis: 2005 Vs. 2004(In INR billion)
  • Table 146: Annual Sales Analysis by BusinessSegment: 2005 Vs. 2004(In INR billion)
• 52. Schering-Plough Corporation (USA)
  • Table 147: First Quarter Sales Analysis:2007 Vs. 2006 (In US$ million)
  • Table 148: First Quarter Sales Analysis by Segment:2007 Vs. 2006 (In US$ million)
  • Table 149: Annual Sales Analysis: 2006 Vs. 2005(In US$ million)
  • Table 150: Quarterly Sales Analysis: 2006 Vs. 2005(In US$ million)
  • Table 151: Annual Sales Analysis by Segment:2006 Vs. 2005 (In US$ million)
  • Table 152: Annual Sales Analysis by GeographicRegion: 2006 Vs. 2005 (In US$ million)
  • Schering-Plough Animal Health Corporation (USA)
  • Schering-Plough Animal Health Limited(New Zealand)
• 53. Shafit - Biological Laboratories Ltd. (Israel)
• 54. Shigeta Animal Pharmaceuticals, Inc. (Japan)
• 55. PT IPB Shigeta Animal Pharmaceuticals Inc. (Japan)
• 56. Bogor Agricultural Institute (IPB) (Indonesia)
• 57. Skystar Bio-pharmaceutical Company (China)
  • Table 153: First Quarter Sales Analysis:2007 Vs. 2006 (In US$ million)
  • Table 154: Annual Sales Analysis: 2006 Vs. 2005(In US$ million)
• 58. Suguna Poultry Farm Ltd. (India)
• 59. Teva Pharmaceutical Industries Ltd. (Israel)
  • Table 155: Market Share by Segment: 2006 Vs. 2005(% Breakdown of Value Sales)
  • Table 156: Market Share by Geographic Region:2006 Vs. 2005 (% Breakdown of Value Sales)
  • Table 157: Annual Sales Analysis: 2004 - 2006(In US$ million)
  • Table 158: Annual Sales Analysis by BusinessSegment: 2006 Vs. 2005 (In US$ million)
  • Table 159: Annual Sales Analysis by GeographicRegion: 2006 Vs. 2005 (In US$ million)
  • Table 160: Annual Sales Analysis by Quarter:2004-2005 (In US$ million)
  • ABIC Biological Laboratories Teva Ltd. (Israel)
• 60. Vaishali Lifecare Pvt., Ltd. (India)
• 61. Veterina Animal Health Ltd. (Croatia)
• 62. Virbac SA (France)
  • Virbac Corporation (USA)
  • Table 161: First Quarter Sales Analysis:2005-2006 (Q1) (In US$ million)
  • Table 162: Annual Sales Analysis: 2003-2005(In US$ million)
  • Table 163: Annual Sales Analysis by Quarter:2004-2005 (In US$ million)
  • Table 164: Annual Sales Analysis by Segment:2004-2005 (In US$ million)
  • Table 165: Annual Sales Analysis by GeographicRegion: 2004-2005 (In US$ million)
• 63. Wyeth (USA)
  • Table 166: Annual Sales Analysis: 2004-2006(In US$ million)
  • Table 167: Annual Sales Analysis by Quarter:2006 Vs. 2005 (In US$ million)
  • Table 168: Annual Sales Analysis by Segment:2006 Vs. 2005 (In US$ million)
  • Table 169: Annual Sales Analysis by GeographicRegion: 2006 Vs.2005 (In US$ million)
  • Fort Dodge Animal Health (USA)
  • Fort Dodge Animal Health Holland BV(The Netherlands)
  • Fort Dodge Laboratories Ireland